AVTX-002

Drug identity checked against registry records

Also recorded as CERC-002, AEVI-002, MDGN-002

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.NCT05288504AVTXPhase 2Completed2023-05-11Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.